AzTrials
AzTrials

Feeding BehaviorNCT03409601

The Role of Satiety in the Effect of Portion Size on Intake

A study testing 100% Portion Size, 125% Portion Size and 150% Portion Size in people with Feeding Behavior, run by Penn State University at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The study uses a crossover design in which the portion size of food is varied at each meal. Across four test meals, subjects will be served four different portions of food, and intake will be determined from pre- and post-meal food weights. Read more about this study

Who is it for?
Ages 20 to 65 years
Conditions the study is for
Feeding Behavior
What is being tested?
100% Portion Size, 125% Portion Size and 150% Portion Size
Could I receive a placebo?
No, everyone receives an active treatment
How many people
14 participants
Where
1 siteUnited States
Study dates
2 Apr 2018to 14 Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Be willing and able to travel to Penn State University Park campus weekly for meals
  • Be a man or woman 18 - 60 years old
  • Regularly eat 3 meals/day
  • Be willing to avoid alcohol the day before and during test days
  • Have a body mass index between 18.0 and 35.0 kg/m-squared
  • Be willing to refrain from eating after 10 pm the evening before test sessions

Who cannot join

  • A smoker
  • An athlete in training
  • Pregnant or breastfeeding at the time of screening
  • Have taken prescription or non-prescription drugs that may affect appetite or food intake within the last 3 months
  • Dislike or be unable to eat the test foods (because of allergies, intolerance, or dietary restrictions)
  • Currently dieting to gain or lose weight
  • Have a health condition that affects appetite
  • Have participated in a similar study in our lab in the past year

Trial locations and contacts

1 site in 1 country.

United States1 site
  • The Pennsylvania State University

    University Park, Pennsylvania, 16802

Other trials in United States

About this study

The study uses a crossover design in which the portion size of food is varied at each meal. Across four test meals, subjects will be served four different portions of food, and intake will be determined from pre- and post-meal food weights. The first visit will be a screening visit, at which subjects will complete the consent form, have their height and weight measured, and rate the taste of the study food. Test meals will be scheduled once a week for four weeks. At visits 2-5, subjects will eat lunch and rate characteristics of the meal. At visit 6, subjects will complete various questionnaires. The objective of this study is to determine whether any individual characteristics related to satiety influence the effect of portion size on intake.

Being tested
100% Portion Size, 125% Portion Size, 150% Portion Size, 175% Portion Size
Keywords
Obesity, eating behavior, food, nutrition
Medical subject headings
Feeding Behavior, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 100% Portion SizeOther

    Meal portion size at baseline

  • 125% Portion SizeOther

    Meal portion size 125% of baseline

  • 150% Portion SizeOther

    Meal portion size 150% of baseline

  • 175% Portion SizeOther

    Meal portion size 175% of baseline

Study groups in NCT03409601
Study groupRoleWhat they receive
100% Portion SizeExperimentalTest meal consists of baseline (100%) portion size of meal.
Receives: Other: 100% Portion Size
125% Portion SizeExperimentalTest meal consists of food portion size that is 125% the size of baseline portion.
Receives: Other: 125% Portion Size
150% Portion SizeExperimentalTest meal consists of food portion size that is 150% the size of baseline portion.
Receives: Other: 150% Portion Size
175% Portion SizeExperimentalTest meal consists of food portion size that is 175% the size of baseline portion.
Receives: Other: 175% Portion Size

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Differences in energy intake

    Calculated energy intake (kcal) based on weight and energy density of food consumed

    Measured: Weeks 1, 2, 3, and 4

  2. Differences in intake by weight

    Weights (grams) of all foods consumed

    Measured: Weeks 1, 2, 3, and 4

Secondary outcomes (5)
  1. Sensory-specific satiety

    Change in taste pleasantness of eaten foods compared to uneaten foods

    Measured: Weeks 1, 2, 3, and 4

  2. Eating rate

    Assessed from meal duration and number of bites taken

    Measured: Weeks 1, 2, 3, and 4

  3. Ratings of hunger and satiety

    100-point visual analog scales

    Measured: Weeks 1, 2, 3, and 4

  4. Ratings of sensory characteristics of the food

    100-point visual analog scales

    Measured: Weeks 1, 2, 3, and 4

  5. Ratings of meal characteristics

    100-point visual analog scales

    Measured: Weeks 1, 2, 3, and 4

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jan 2018
  2. Study start2 Apr 2018
  3. Primary completion14 Dec 2018
  4. Study completion14 Dec 2018

Why it stopped: Additional outcome measures have been developed and added to the protocol.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
14 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03409601
Sponsor's protocol ID
PortionSize104
Status last verified
Mar 2019
First submitted
18 Jan 2018
Last updated
18 Mar 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing 100% Portion Size, 125% Portion Size and 150% Portion Size in people with Feeding Behavior, run by Penn State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 18 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Additional outcome measures have been developed and added to the protocol.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Differences in energy intake (time frame: Weeks 1, 2, 3, and 4). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in